share_log

FIGS Analyst Ratings

Benzinga ·  Aug 7, 2023 18:41
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/07/2023 -1.13% Barclays $5 → $7 Maintains Underweight
08/04/2023 55.37% Telsey Advisory Group → $11 Reiterates Outperform → Outperform
07/28/2023 55.37% Telsey Advisory Group → $11 Reiterates Outperform → Outperform
07/21/2023 55.37% Telsey Advisory Group → $11 Reiterates Outperform → Outperform
07/17/2023 — Raymond James Downgrades Outperform → Market Perform
06/08/2023 41.24% TD Cowen $8 → $10 Maintains Outperform
05/08/2023 -29.38% Barclays $4 → $5 Maintains Underweight
05/05/2023 27.12% Raymond James $10 → $9 Maintains Outperform
05/03/2023 27.12% Roth MKM → $9 Initiates Coverage On → Buy
05/02/2023 — Barclays Downgrades Equal-Weight → Underweight
04/27/2023 55.37% Telsey Advisory Group → $11 Reiterates → Outperform
03/21/2023 27.12% Oppenheimer $12 → $9 Maintains Outperform
03/02/2023 -11.72% Goldman Sachs $5.5 → $6.25 Maintains Sell
03/01/2023 41.24% Credit Suisse $12 → $10 Maintains Outperform
03/01/2023 -11.72% Goldman Sachs $5.5 → $6.25 Maintains Sell
03/01/2023 55.37% Telsey Advisory Group $12 → $11 Maintains Outperform
02/22/2023 69.49% Telsey Advisory Group $9 → $12 Maintains Outperform
02/01/2023 41.24% Raymond James $8 → $10 Maintains Outperform
01/31/2023 55.37% Cowen & Co. $6 → $11 Maintains Market Perform
11/17/2022 69.49% Oppenheimer $22 → $12 Maintains Outperform
11/14/2022 -22.32% Goldman Sachs $7.5 → $5.5 Maintains Sell
11/14/2022 -15.25% Barclays $9 → $6 Maintains Equal-Weight
11/11/2022 -1.13% Morgan Stanley $10 → $7 Maintains Equal-Weight
11/11/2022 12.99% Raymond James $12 → $8 Downgrades Strong Buy → Outperform
11/11/2022 27.12% Telsey Advisory Group $10 → $9 Maintains Outperform
11/08/2022 69.49% Raymond James $15 → $12 Maintains Strong Buy
11/04/2022 41.24% Telsey Advisory Group $17 → $10 Maintains Outperform
10/25/2022 41.24% Morgan Stanley $11 → $10 Maintains Equal-Weight
10/14/2022 27.12% Barclays $15 → $9 Downgrades Overweight → Equal-Weight
08/08/2022 55.37% Morgan Stanley $12 → $11 Maintains Equal-Weight
08/05/2022 111.86% Barclays $13 → $15 Maintains Overweight
07/21/2022 — Keybanc Initiates Coverage On → Sector Weight
07/21/2022 -1.13% Goldman Sachs $14 → $7 Downgrades Neutral → Sell
06/30/2022 111.86% Raymond James → $15 Initiates Coverage On → Strong Buy
05/16/2022 83.62% Barclays $34 → $13 Maintains Overweight
05/16/2022 210.73% Oppenheimer $45 → $22 Maintains Outperform
05/16/2022 69.49% B of A Securities $32 → $12 Downgrades Buy → Neutral
05/13/2022 69.49% Morgan Stanley $25 → $12 Maintains Equal-Weight
05/13/2022 111.86% Credit Suisse $26 → $15 Maintains Outperform
05/13/2022 196.61% Telsey Advisory Group $30 → $21 Maintains Outperform
04/07/2022 351.98% Truist Securities → $32 Initiates Coverage On → Buy
03/10/2022 380.23% Barclays $38 → $34 Maintains Overweight
03/09/2022 351.98% B of A Securities $40 → $32 Maintains Buy
03/09/2022 408.47% Piper Sandler $45 → $36 Maintains Overweight
03/09/2022 267.23% Credit Suisse $34 → $26 Maintains Outperform
03/03/2022 323.73% Telsey Advisory Group $46 → $30 Maintains Outperform
03/01/2022 323.73% Goldman Sachs $35 → $30 Maintains Neutral
02/07/2022 — Cowen & Co. Downgrades Outperform → Market Perform
01/20/2022 380.23% Keybanc $45 → $34 Maintains Overweight
01/11/2022 380.23% Credit Suisse $42 → $34 Maintains Outperform
11/11/2021 493.22% Credit Suisse $41 → $42 Maintains Outperform
08/13/2021 408.47% Morgan Stanley $34 → $36 Maintains Equal-Weight
08/13/2021 549.72% Telsey Advisory Group $43 → $46 Maintains Outperform
06/21/2021 507.34% Cowen & Co. → $43 Initiates Coverage On → Outperform
06/21/2021 493.22% B of A Securities → $42 Initiates Coverage On → Buy
06/21/2021 295.48% Goldman Sachs → $28 Initiates Coverage On → Neutral
06/21/2021 535.59% Oppenheimer → $45 Initiates Coverage On → Outperform
06/21/2021 380.23% Morgan Stanley → $34 Initiates Coverage On → Equal-Weight
06/21/2021 507.34% Telsey Advisory Group → $43 Initiates Coverage On → Outperform
06/21/2021 606.21% Barclays → $50 Initiates Coverage On → Overweight
06/21/2021 394.35% Piper Sandler → $35 Initiates Coverage On → Overweight
06/21/2021 535.59% Keybanc → $45 Initiates Coverage On → Overweight

What is the target price for FIGS (FIGS)?

The latest price target for FIGS (NYSE: FIGS) was reported by Barclays on August 7, 2023. The analyst firm set a price target for $7.00 expecting FIGS to fall to within 12 months (a possible -1.13% downside). 30 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for FIGS (FIGS)?

The latest analyst rating for FIGS (NYSE: FIGS) was provided by Barclays, and FIGS maintained their underweight rating.

When is the next analyst rating going to be posted or updated for FIGS (FIGS)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of FIGS, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for FIGS was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.

Is the Analyst Rating FIGS (FIGS) correct?

While ratings are subjective and will change, the latest FIGS (FIGS) rating was a maintained with a price target of $5.00 to $7.00. The current price FIGS (FIGS) is trading at is $7.08, which is out of the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment